Literature DB >> 15761608

Subclinical form of the American visceral leishmaniasis.

Mônica Elinor Alves Gama1, Jackson Maurício Lopes Costa, Cláudia Maria Castro Gomes, Carlos Eduardo Pereira Corbett.   

Abstract

The subclinical form of visceral leishmaniasis (VL) shows nonspecific clinical manifestations, with difficulties being frequently met in its clinical characterization and diagnostic confirmation. Thus, the objective of the present study was to define the clinical-laboratory profile of this clinical form. A cohort study was conducted in the state of Maranhão, Brazil, from January/1998 to December/2000, with monthly follow-up of 784 children aged 0-5 years. Based on the clinical-laboratory parameters reported in the literature, four categories were established, with the children being classified (according to their clinical-evolutive behavior) as asymptomatic (N = 144), as having the subclinical form (N = 33) or the acute form (N = 12) or as subjects "without VL" (N = 595). Multiple discriminant analysis demonstrated that the combination of fever, hepatomegaly, hyperglobulinemia, and increased blood sedimentation rate (BSR) can predict the subclinical form of VL as long as it is not associated with splenomegaly or leukopenia. Subjects with the subclinical form did not show prolonged or intermittent evolution or progression to the acute form of VL. Subclinical cases have a profile differing from the remaining clinical forms of VL, being best characterized by the combination of fever, hepatomegaly, hyperglobulinemia, and increased BSR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761608     DOI: 10.1590/s0074-02762004000800018

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

1.  Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.

Authors:  Fernando Tobias Silveira; Ralph Lainson; Adelson Alcimar Almeida De Souza; Marliane Batista Campos; Liliane Almeida Carneiro; Luciana Vieira Rego Lima; Patrícia Karla Santos Ramos; Cláudia Maria de Castro Gomes; Marcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2009-11-28       Impact factor: 2.289

2.  Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.

Authors:  Luciana Vieira do Rêgo Lima; Patrícia Karla Santos Ramos; Marliane Batista Campos; Thiago Vasconcelos dos Santos; Claudia Maria de Castro Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Pathog Glob Health       Date:  2014-12-09       Impact factor: 2.894

3.  Visceral leishmaniasis: A case report.

Authors:  Sachin Gawade; Mangesh Nanaware; Rm Gokhale; Ps Adhav
Journal:  Australas Med J       Date:  2012-02-29

4.  A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence.

Authors:  Fernando T Silveira; Ralph Lainson; Elza A Pereira; Adelson A A de Souza; Marliane B Campos; Eugênia J Chagas; Claudia M C Gomes; Márcia D Laurenti; Carlos E P Corbett
Journal:  Parasitol Res       Date:  2008-10-21       Impact factor: 2.289

5.  Epidemiologic aspects of an emerging focus of visceral leishmaniasis in Tbilisi, Georgia.

Authors:  Ekaterina Giorgobiani; Nazibrola Chitadze; Gvantsa Chanturya; Marina Grdzelidze; Ryan C Jochim; Anna Machablishvili; Tsiuri Tushishvili; Yulia Zedginidze; Marina K Manjgaladze; Nino Iashvili; Manana P Makharadze; Tsiuri Zakaraya; Konstantin Kikaleishvili; Ivan Markhvashvili; Goderdzi Badashvili; Teymuraz Daraselia; Michael P Fay; Shaden Kamhawi; David Sacks
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

6.  Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.

Authors:  Patrícia Karla Ramos; Karina Inácio Carvalho; Daniela Santoro Rosa; Ana Paula Rodrigues; Luciana Vieira Lima; Marliane Batista Campos; Claudia Maria C Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Corbett; Fernando Tobias Silveira
Journal:  Biomed Res Int       Date:  2016-03-08       Impact factor: 3.411

7.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

8.  New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control.

Authors:  Luciana Lima; Thiago Vasconcelos-Dos-Santos; Marliane Campos; Patrícia Karla Ramos; Claudia Gomes; Marcia Laurenti; Vania da Matta; Carlos Corbett; Fernando Silveira
Journal:  Parasite Epidemiol Control       Date:  2020-05-08

9.  Inaccuracy of enzyme-linked immunosorbent assay using soluble and recombinant antigens to detect asymptomatic infection by Leishmania infantum.

Authors:  Elizabeth Castro Moreno; Andréa Vieira Gonçalves; Anderson Vieira Chaves; Maria Norma Melo; José Roberto Lambertucci; Antero Silva Ribeiro Andrade; Deborah Negrão-Corrêa; Carlos Mauricio de Figueiredo Antunes; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2009-10-20

10.  Atypical systemic leishmaniasis to be considered in the differential of patients presenting with depressed immunity.

Authors:  Nuha Nuwayri-Salti; Khouzama Knio; Adham Jammoul; Rajaa Fakhoury; Karim A Sarhane; Hania Nakkash-Chmaisse
Journal:  PLoS Negl Trop Dis       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.